Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia

3-(2,4-Dimethoxybenzylidene)-anabaseine (DMXB-A) is a partial agonist at α7-nicotinic acetylcholine receptors and is now in early clinical development for treatment of deficits in neurocognition and sensory gating in schizophrenia. During its initial phase 2 test, functional magnetic resonance imagi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tregellas, Jason R, Olincy, Ann, Johnson, Lynn, Tanabe, Jody, Shatti, Shireen, Martin, Laura F, Singel, Debra, Du, Yiping P, Soti, Ferenc, Kem, William R, Freedman, Robert
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834253/
https://ncbi.nlm.nih.gov/pubmed/19956085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2009.196
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares